The P3 event-related potential is a biomarker for the efficacy of vagus nerve stimulation in patients with epilepsy

scientific article

The P3 event-related potential is a biomarker for the efficacy of vagus nerve stimulation in patients with epilepsy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S13311-014-0272-3
P932PMC publication ID4121454
P698PubMed publication ID24711167
P5875ResearchGate publication ID261444898

P50authorDirk Van RoostQ123200032
Ine DauweQ123200041
Lies MolletQ123200049
Leen De TaeyeQ123200067
Tom VergutsQ45896549
Pieter van MierloQ47985201
Veerle De HerdtQ49072263
Paul BoonQ87110922
Kristl VonckQ87110930
Robrecht RaedtQ87110933
Stefanie GadeyneQ87634636
Evelien CarretteQ90637962
Alfred MeursQ123200007
P2093author name stringMarlies van Bochove
P2860cites workUpdating P300: an integrative theory of P3a and P3bQ24645237
Orienting and reorienting: the locus coeruleus mediates cognition through arousalQ28276475
An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performanceQ29615396
The effects of peripheral vagal nerve stimulation at a memory-modulating intensity on norepinephrine output in the basolateral amygdalaQ30312117
Vagus nerve stimulation for partial seizures.Q32064483
Effect of vagal nerve stimulation on auditory and visual event-related potentialsQ33182414
Cancellation of EEG and MEG signals generated by extended and distributed sourcesQ33554917
Enhanced recognition memory following vagus nerve stimulation in human subjectsQ33858053
Vagus nerve stimulation for refractory epilepsy.Q34432642
Safety and efficacy of Vagus Nerve Stimulation in treatment-resistant depression. A systematic reviewQ34589824
Vagus-nerve stimulation for the treatment of epilepsyQ35172370
Common pathogenic mechanisms between depression and epilepsy: an experimental perspectiveQ35573294
Response activation impairments in schizophrenia: evidence from the lateralized readiness potentialQ35618956
Decision making, the P3, and the locus coeruleus-norepinephrine systemQ36214791
Clinical experience with vagus nerve stimulation and deep brain stimulation in epilepsyQ36906874
The locus coeruleus and noradrenergic modulation of cognitionQ37384698
Event-related potentials in clinical research: guidelines for eliciting, recording, and quantifying mismatch negativity, P300, and N400.Q37606808
The anatomical and functional relationship between the P3 and autonomic components of the orienting responseQ37765930
A roadmap for the development and validation of event-related potential biomarkers in schizophrenia researchQ37812747
Vagus nerve stimulation in 436 consecutive patients with treatment-resistant epilepsy: long-term outcomes and predictors of responseQ37818749
Depression and epilepsy: A bidirectional relation?Q37826767
The role of locus coeruleus in the antiepileptic activity induced by vagus nerve stimulationQ37871070
Vagus nerve stimulation for epilepsy: a meta-analysis of efficacy and predictors of response.Q37916564
Effects of locus coeruleus lesions on auditory, long-latency, event-related potentials in monkey.Q41275415
Increased extracellular concentrations of norepinephrine in cortex and hippocampus following vagus nerve stimulation in the ratQ41782749
Effect of vagus nerve stimulation on serotonergic and noradrenergic transmissionQ42495232
Vagus nerve stimulation for refractory epilepsy: a Belgian multicenter studyQ42616023
Cognition-enhancing effect of vagus nerve stimulation in patients with Alzheimer's disease: a pilot studyQ42688507
Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulationQ44233180
Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizuresQ46272251
Pupillometry and P3 index the locus coeruleus-noradrenergic arousal function in humansQ46540087
Vagus nerve stimulation increases norepinephrine concentration and the gene expression of BDNF and bFGF in the rat brain.Q46962887
Efferent projections of the nucleus of the solitary tract to peri-locus coeruleus dendrites in rat brain: evidence for a monosynaptic pathwayQ48140596
Electrophysiologic studies of cervical vagus nerve stimulation in humans: II. Evoked potentialsQ48411646
Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodesQ48766109
Auditory event-related potentials (P300) in epileptic patientsQ48825150
Recordings from the rat locus coeruleus during acute vagal nerve stimulation in the anaesthetised rat.Q48922181
Increased hippocampal noradrenaline is a biomarker for efficacy of vagus nerve stimulation in a limbic seizure modelQ49072157
Long-term results of vagus nerve stimulation in refractory epilepsyQ49169890
Transcutaneous vagus nerve stimulation (t-VNS) in pharmacoresistant epilepsies: a proof of concept trial.Q50581052
Vagus nerve stimulation is associated with mood improvements in epilepsy patients.Q51073580
Long-term effects of 24-month treatment with vagus nerve stimulation on behaviour in children with Lennox-Gastaut syndrome.Q51950285
The effects of vagus nerve stimulation on cognitive performance in patients with treatment-resistant depression.Q52021212
Comparative cognitive effects of phenobarbital, phenytoin, and valproate in healthy adultsQ52052129
P300 is enhanced in responders to vagus nerve stimulation for treatment of major depressive disorder.Q52929200
The locus coeruleus–noradrenergic system: modulation of behavioral state and state-dependent cognitive processesQ55921579
The effect of the skull on event-related P300Q57411418
A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures. The Vagus Nerve Stimulation Study GroupQ72541815
A Pilot Study of Mood in Epilepsy Patients Treated with Vagus Nerve StimulationQ73057238
Guidelines for using human event-related potentials to study cognition: recording standards and publication criteriaQ73581007
Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trialQ74800943
Vagus nerve stimulation for refractory epilepsy in children: More to VNS than seizure frequency reductionQ83241819
P433issue3
P921main subjectbiomarkerQ864574
P304page(s)612-622
P577publication date2014-07-01
P1433published inNeurotherapeuticsQ15716631
P1476titleThe P3 event-related potential is a biomarker for the efficacy of vagus nerve stimulation in patients with epilepsy
P478volume11

Reverse relations

cites work (P2860)
Q53076902Application of the P300 Event-Related Potential in the Diagnosis of Epilepsy Disorder: A Review.
Q30404737Beta receptor-mediated modulation of the oddball P3 but not error-related ERP components in humans
Q36177113Catecholaminergic Regulation of Learning Rate in a Dynamic Environment
Q38759738Clinical Vagus Nerve Stimulation Paradigms Induce Pronounced Brain and Body Hypothermia in Rats
Q92510251Current Directions in the Auricular Vagus Nerve Stimulation II - An Engineering Perspective
Q48485966EEG Derived Brain Activity Reflects Treatment Response from Vagus Nerve Stimulation in Patients with Epilepsy
Q48041066Epilepsy: closing the loop for patients with epilepsy
Q58097939Invasive Neuromodulation for the Treatment of Pediatric Epilepsy
Q40559096Noradrenergic and cholinergic modulation of late ERP responses to deviant stimuli
Q47687069Open your eyes for prediction errors.
Q48478224The effect of vagus nerve stimulation on response inhibition
Q38585905Vagus Nerve and Vagus Nerve Stimulation, a Comprehensive Review: Part III.
Q57170309Vagus nerve stimulation as a tool for enhancing extinction in exposure-based therapies

Search more.